17412 Federal Register / Vol. 78, No. 55 / Thursday, March 21, 2013 / Notices 

Review Officer, CDC, 1600 Clifton Road NE., 

Mailstop D–72, Atlanta, Georgia 30333, 

Telephone: (404) 639–4796. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dana Redford, 

Acting Director, Management Analysis and 

Services Office Centers for Disease Control 

and Prevention. 

[FR Doc. 2013–06438 Filed 3–20–13; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Initial Review 

The meeting announced below 

concerns Strengthening the Monitoring 

and Evaluation of Programs for the 

Elimination and Control of Neglected 

Tropical Diseases in Africa, FOA GH13– 

002, initial review. 

In accordance with Section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the aforementioned meeting: 

Time and Date: 1:00 p.m.–4:30 p.m., May 

23, 2013 (Closed). 

Place: Teleconference. 

Status: The meeting will be closed to the 

public in accordance with provisions set 

forth in Section 552b(c)(4) and (6), Title 5 

U.S.C., and the Determination of the Director, 

Management Analysis and Services Office, 

CDC, pursuant to Public Law 92–463. 

Matters To Be Discussed: The meeting will 

include the initial review, discussion, and 

evaluation of applications received in 

response to ‘‘Strengthening the Monitoring 

and Evaluation of Programs for the 

Elimination and Control of Neglected 

Tropical Diseases in Africa, FOA GH13–002, 

initial review.’’ 

Contact Person for More Information: 

Diana Bartlett, Scientific Review Officer, 

Office of the Associate Director for Science, 

Office of Science Quality, CDC, 1600 Clifton 

Road NE., Mailstop D–72, Atlanta, Georgia 

30033, Telephone (404) 639–4938, 

zxd5@cdc.gov. 

The Director, Management Analysis and 

Services Office, has been delegated the 

authority to sign Federal Register notices 

pertaining to announcements of meetings and 

other committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dana Redford, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2013–06437 Filed 3–20–13; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP): Funding 

Opportunity Announcement, Initial 

Review 

The meeting announced below 

concerns Indoor Environment of LowIncome Renovated Multifamily Housing 

in the Western Region of the United 

States (U01), FOA EH13–001, initial 

review. 

SUMMARY: This document corrects a 

notice that was published in the Federal 

Register on February 28, 2013 (78 FR 

13677). The meeting announcement and 

matters to be discussed should read as 

follows: 

The meeting announced below 

concerns Indoor Environment of LowIncome Renovated Multifamily Housing 

in the Western Region of the United 

States (U01), FOA EH13–001, initial 

review. 

Matters To Be Discussed: The meeting 

will include the initial review, 

discussion, and evaluation of 

applications received in response to 

‘‘Indoor Environment of Low-Income 

Renovated Multifamily Housing in the 

Western Region of the United States 

(U01), FOA EH13–001’’. 

FOR FURTHER INFORMATION CONTACT: J. 

Felix Rogers, Ph.D., M.P.H., Scientific 

Review Officer, CDC, 4770 Buford 

Highway NE., Mailstop F63, Atlanta, 

Georgia 30341, Telephone: (770) 488– 

4334. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both the 

Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Dana Redford, 

Acting Director, Management Analysis and 

Services Office, Centers for Disease Control 

and Prevention. 

[FR Doc. 2013–06434 Filed 3–20–13; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Medicare & Medicaid 

Services 

[Document Identifier CMS–R–218] 

Agency Information Collection 

Activities: Submission for OMB 

Review; Comment Request 

AGENCY: Centers for Medicare & 

Medicaid Services, HHS. 

In compliance with the requirement 

of section 3506(c)(2)(A) of the 

Paperwork Reduction Act of 1995, the 

Centers for Medicare & Medicaid 

Services (CMS) is publishing the 

following summary of proposed 

collections for public comment. 

Interested persons are invited to send 

comments regarding this burden 

estimate or any other aspect of this 

collection of information, including any 

of the following subjects: (1) The 

necessity and utility of the proposed 

information collection for the proper 

performance of the agency’s functions; 

(2) the accuracy of the estimated 

burden; (3) ways to enhance the quality, 

utility, and clarity of the information to 

be collected; and (4) the use of 

automated collection techniques or 

other forms of information technology to 

minimize the information collection 

burden. 

1. Type of Information Collection 

Request: Reinstatement of a previously 

approved collection; Title of 

Information Collection: Health 

Insurance Portability and 

Accountability Act (HIPAA) Standards 

for Electronic Transactions and 

Supporting Regulations in 45 CFR Part 

162. Use: This information collection 

request has no substantive changes 

since the last OMB approval in 2008. 

The adopted transaction standards 

currently in use for electronic 

transactions (Version 4010/4010a) are 

compatible with the ICD–9–CM adopted 

code set that is used to report diagnoses 

and hospital inpatient services. 

However, the ICD–10 codes cannot be 

used with Version 4010/4010a, because 

this version does not have a specific 

qualifier or indicator for reporting ICD– 

10 codes. 

Version 5010 supports the use of the 

ICD–10 code set by making available a 

qualifier to indicate that an ICD–10 code 

is being reported. Like ICD–9, ICD–10 

codes are reported in claim and 

payment transactions, as well as 

eligibility inquiries and responses and 

requests for referrals and authorizations. 

In Version 5010, the number of codes 

required in any given transaction does 

not change. It is possible that a fewer 


emcdonald on DSK67QTVN1PROD with NOTICES
Federal Register / Vol. 78, No. 55 / Thursday, March 21, 2013 / Notices 17413 

number of codes in a given transaction 

may be necessary to report the same 

information reported with ICD–9 codes 

because ICD–10 codes are more specific. 

Form Number: CMS–R–218 (OCN: 

0938–0866). Frequency: Occasionally. 

Affected Public: Private Sector (Business 

or other for-profits, Not-for-profit 

institutions). Number of Respondents: 

696,026. Total Annual Responses: 

696,026. Total Annual Hours: 6,960,260. 

(For policy questions regarding this 

collection contact Gladys Wheeler at 

410–786–0273. For all other issues call 

410–786–1326.) 

To obtain copies of the supporting 

statement and any related forms for the 

proposed paperwork collections 

referenced above, access CMS’ Web site 

address at http://www.cms.hhs.gov/ 

PaperworkReductionActof1995, or 

Email your request, including your 

address, phone number, OMB number, 

and CMS document identifier, to 

Paperwork@cms.hhs.gov, or call the 

Reports Clearance Office on (410) 786– 

1326. 

To be assured consideration, 

comments and recommendations for the 

proposed information collections must 

be received by the OMB desk officer at 

the address below, no later than 5 p.m. 

on April 22, 2013. 

OMB, Office of Information and 

Regulatory Affairs, Attention: CMS Desk 

Officer, Fax Number: (202) 395–6974, 

Email: OIRA_submission@omb.eop.gov. 

Dated: March 18, 2013. 

Martique Jones, 

Deputy Director, Regulations Development 

Group, Office of Strategic Operations and 

Regulatory Affairs. 

[FR Doc. 2013–06534 Filed 3–20–13; 8:45 am] 

BILLING CODE 4120–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

[CFDA Number: 93.576] 

Announcement of the Award of an 

Urgent Single-Source Grant to the 

Center for Survivors of Torture in 

Dallas, TX 

AGENCY: Office of Refugee Resettlement, 

Administration for Children and 

Families, Department of Health and 

Human Services. 

ACTION: Announcement of the award of 

an urgent single-source grant to the 

Center for Survivors of Torture to 

provide mental health services for 

refugees. 

SUMMARY: The Administration for 

Children and Families (ACF), Office of 

Refugee Resettlement (ORR) announces 

the award of an urgent single-source 

grant in the amount of $250,000 to the 

Center for Survivors of Torture (CST) in 

Dallas, TX to ensure incoming refugee 

populations in Texas have access to 

mental health services. 

DATES: The project period for the award 

is February 1, 2013 through January 31, 

2014. 

FOR FURTHER INFORMATION CONTACT: 

Kenneth Tota, Deputy Director, Office of 

Refugee Resettlement, 901 D Street SW., 

Washington, DC 20047. Telephone: 

202–401–4858. Email: 

kenneth.tota@acf.hhs.gov. 

SUPPLEMENTARY INFORMATION: 

Approximately 45,000 individual 

refugees reside in the areas covered by 

the Center for Survivors of Torture. 

Texas and the surrounding region have 

a demonstrated history of being a top 

resettlement location with one of the 

highest concentrations of refugees in the 

United States. In the past few years, the 

Office of Refugee Resettlement (ORR) 

has seen an increasing need for mental 

health services associated with the three 

primary refugee populations from Iraq, 

Burma and Bhutan who have suffered 

extreme trauma and torture due to war 

and genocide in those countries. 

Refugees from Bhutan have specifically 

demonstrated a high incidence of 

suicide upon arrival to the U.S. ORR has 

been working closely with the Centers 

for Disease Control (CDC) to assess this 

situation. The CDC recently published a 

study recommending enhanced mental 

health services for incoming refugees 

from Bhutan. 

This fiscal year the program is seeing 

a significant increase in resettlement of 

refugees from the Democratic Republic 

of Congo. The United Nations High 

Commissioner for Refugees (UNHCR) 

has determined this group is 

particularly at risk due to decades of 

extreme violence in the Democratic 

Republic of Congo and recent arrivals 

have shown a compelling need for 

mental health services upon arrival. 

Furthermore, CST is the only accredited 

mental health care provider of 

specialized refugee mental health 

treatment services in Texas and the 

surrounding area. 

CST services are critical to meeting 

refugee mental health needs by 

providing services such as an initial 

assessment, counseling to: children, 

adolescents, adults, couples, and 

families. Additionally, CST provides 

group therapy, psychoeducational 

groups, testing for mental health 

conditions, and medication 

management. In addition to these direct 

services, CST also provides training to 

other agencies in the area to include 

schools, health clinics, and social 

services agencies on refugee mental 

health issues. 

Due to the high number of refugees 

being resettled in this region, with no 

other demonstrated provider of expert 

mental health services to this 

population, this grant is urgent and 

critical to those in need of such services. 

According to the Department of State, 

Texas is projected to receive the highest 

number of refugees admitted to the U.S. 

in FY13. Through this grant ORR will 

ensure there is no disruption in much 

needed mental health services to these 

particularly at risk populations. This 

urgent grant will support the provision 

of these much needed mental health 

services to ensure these refugees are 

afforded a successful path to selfsufficiency. 

Statutory Authority: Section 412 

(c)(1)(A)(iii) of the Immigration and 

Nationality Act, as amended and the Refugee 

Assistance Extension Act of 1986, Pub. L. 99– 

605 (8 U.S.C. 1101). 

Eskinder Negash, 

Director, Office of Refugee Resettlement. 

[FR Doc. 2013–06517 Filed 3–20–13; 8:45 am] 

BILLING CODE 4184–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2013–N–0001] 

Pulmonary-Allergy Drugs Advisory 

Committee; Notice of Meeting 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

This notice announces a forthcoming 

meeting of a public advisory committee 

of the Food and Drug Administration 

(FDA). The meeting will be open to the 

public. This meeting is being 

rescheduled due to the postponement of 

the March 7, 2013, Pulmonary-Allergy 

Drugs Advisory Committee meeting due 

to unanticipated weather conditions. 

Name of Committee: PulmonaryAllergy Drugs Advisory Committee. 

General Function of the Committee: 

To provide advice and 

recommendations to the Agency on 

FDA’s regulatory issues. 

Date and Time: The meeting will be 

held on April 17, 2013, from 8 a.m. to 

5 p.m. This meeting is being 

rescheduled because of a postponed 

meeting announced in the Federal 


emcdonald on DSK67QTVN1PROD with NOTICES